Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic and therapeutic implication of molecular classification including L1CAM expression in high-risk endometrial cancer.

Gynecologic oncology - 1 Jan 2025

Kleppe Andreas, Lindemann Kristina, Kildal Wanja, Tobin Kari Anne R, Pradhan Manohar, Vlatkovic Ljiljana, Isaksen Maria X, Danielsen Håvard E, Askautrud Hanne A, Kristensen Gunnar B

Abstract excerpt

INTRODUCTION: The role of molecular classification and L1CAM in high-risk endometrial cancer is uncertain. We aimed to determine the association of molecular profiling and L1CAM with patterns of relapse and survival. MATERIAL AND METHODS: This retrospective cohort study included patients referred to Department for Gynecologic Oncology, Oslo University Hospital between January 1, 2006 and December 31, 2017. L1CAM...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to DNA Polymerase II

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Neoplasm Recurrence, Local

Share to Neural Cell Adhesion Molecule L1

Share to Poly-ADP-Ribose Binding Proteins

Share to Prognosis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 39549540
DOI: 10.1016/j.ygyno.2024.11.005

Genes

L1CAM
TTR
POLE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic and therapeutic implication of molecular classification including L1CAM expression in high-risk endometrial cancer.PMID 39549540Read ↗

Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancer.Semantic proximity Read ↗

Enhanced risk stratification in early-stage endometrial cancer: Integrating Molucular-L1CAM Classification and Simplified L1CAM/p53 CategorizationSemantic proximity Read ↗

Toward Biology-Driven Surveillance After Endometrial Cancer Treatment: A Molecular–Clinical Framework Integrating Recurrence PhenotypeSemantic proximity Read ↗

Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.Semantic proximity Read ↗

The prognosis of endometrial cancers stratified with conventional risk factors and modified molecular classificationSemantic proximity Read ↗

Implementation of the ProMisE classifier and validation of its prognostic impact in Brazilian endometrial carcinomasSemantic proximity Read ↗

Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.Semantic proximity Read ↗

Impact of molecular classification on recurrence risk in endometrial cancer patients with lymph node metastasis: multicenter retrospective study.Semantic proximity Read ↗

Association of Molecular Classification with FIGO Stage and Survival Outcomes in Endometrial Cancer.Semantic proximity Read ↗

Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.Semantic proximity Read ↗

Clinicopathologic Evaluation of CTNNB1 Mutations in High-Intermediate Risk Endometrial Endometrioid Carcinoma.Semantic proximity Read ↗

Molecular classification of endometrial cancer: preliminary experience from a single Portuguese academic center.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.